1. Role: Director. Scope: Department. Date: 2019.
Grant H. Skrepnek, Ph.D., R.Ph.
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47105
Fax (4050 271-6430
Office CPB 214
Email grant-skrepnek@ouhsc.edu
Summary
I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Research
Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Publications & Presentations
- 26. Miller J L, Ernst K, Neely S, Stephens K, Barker P, Skrepnek G H, Johnson P N. Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome. Journal of opioid management. 2019; 15 : 159-167
27. Tieu J D, Williams R J, Skrepnek G H, Gentry C A. Clinical outcomes of fidaxomicin vs oral vancomycin in recurrent Clostridium difficile infection. Journal of Clinical Pharmacy and Therapeutics. 2019; 44 : 220–228
28. Keast S, Holderread B, Cothran T, Skrepnek G H. Hepatitis C Direct-Acting Antiviral Treatment Selection, Treatment Failure, and Use of Drug-Drug Interactions in a State Medicaid Program. Journal of Managed Care and Specialty Pharmacy. 2019; 25 : 1261-1267
29. Medina M, Schwier N C, Miller J L, Miller M M, Skrepnek G. Career skills assessment in a doctor of pharmacy curriculum. American Journal of Pharmacy Education. 2018; 82 : 6300
30. Gilligan A M, Alberts D S, Roe D J, Skrepnek G H. Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer. American Journal of Medicine. 2018; 131 : 1187-1199
Grants
- 11. Improving the Health of Americans through Prevention and Management of Diabetes, Heart Disease, and Stroke. Non-federal. Start Date: 2019. End Date: 2020.
12. Allergan (PI: Keast). Federal Non-NIH. Start Date: 2018. End Date: 2019.
13. Otsuka (Skrepnek/Keast PI). Non-federal. Start Date: 2018. End Date: 2019.
14. Research Fellowship. PhRMA. Start Date: 2017. End Date: 2018.
15. Development of a Predictive Model for METAVIR Fibrosis Scores for Patients Chronically Infected with Hepatitis C Virus. Misc Non-Federal. Start Date: 2017.
Awards and Honors
no results
Education
no results
Administrative Assignments
2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.